About: Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 2001

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2001 (uk) im August 2001 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'agostu de 2001 (ast) scientific article published on 01 August 2001 (en)
publication date	wds:Q63199205-C607DF67-37EC-4643-913E-8A20C4BD4243
publication date	2001-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q63199205-1FFBC1ED-0CC6-4FD3-8C62-75AAB794D674
language of work or name	English
cites work	wds:Q63199205-02894455-471B-4129-B782-B895F1244DCE wds:Q63199205-117FA188-61B6-4DD1-8AF9-987137F0CC65 wds:Q63199205-23548E3D-8E65-4BEF-A4C6-50885BF00D8A wds:Q63199205-284528C0-EA52-4DE9-9814-199485CA6A82 wds:Q63199205-3189AB37-F495-4CE7-8194-E3EEE057BB1F wds:Q63199205-32CA3076-EB8D-49B9-92FC-0376B0DFEE9C wds:Q63199205-3D34C66C-EF48-4399-906F-08E38BCCD4A5 wds:Q63199205-5338E662-5D5C-4CA0-9C2A-09A45F5F1753 wds:Q63199205-56F452F2-4E13-45E9-A7AB-0C7D843F5C3E wds:Q63199205-6845B6FF-04EA-4C2E-BA5A-3E41D8AAC085 wds:Q63199205-6E2FDA4F-B1AC-4599-92D5-CBE4063C4F0D wds:Q63199205-6F4A175A-8CA1-4E30-A861-0A21D7595092 wds:Q63199205-72BE3E35-7B03-4901-B01E-7A1902B85C2F wds:Q63199205-85ACA8D1-D853-4CA5-BFD8-D75BBAD16E62 wds:Q63199205-8A74D414-9B20-4C13-8D12-39103F813A43 wds:Q63199205-8DB62D1F-19ED-45AA-A354-90D9AE64A8D3 wds:Q63199205-8E23E348-94FD-4CD9-92EB-EC854B949CC0 wds:Q63199205-9A7D5437-E50D-4FCA-BEE0-EB789C0CC23B wds:Q63199205-A510D990-9A2C-41F9-B0B1-E5E33A30FDB8 wds:Q63199205-AA6E8C69-8D74-4189-A143-C0B2CDEE2B04 wds:Q63199205-AD4EFBC0-E22B-451B-8E65-97C3552F1F56 wds:Q63199205-BA1A25C4-8C34-417B-9B08-A292E82D46BC wds:Q63199205-C23F4B1E-E4CE-434C-994E-AAA1189C3179 wds:Q63199205-C4AA81C0-45DD-4749-B55C-53C814E62247 wds:Q63199205-CE1ECCD0-56D1-4301-B485-3EE4F2E112E8 wds:Q63199205-D77E9501-9453-4D26-89CB-83F3BCF94A6D wds:Q63199205-D8D951FE-CBA4-49DE-B24C-B8981C08A300 wds:Q63199205-DC5BD3A6-2355-4BE7-A9EF-8D830D6D5207 wds:Q63199205-DEAF0A04-3C50-45AA-9636-82CB48D6A0C2 wds:Q63199205-E2B1AB4F-AD27-494C-9C3A-C1943DC91BFC wds:Q63199205-E36EDE03-68DA-4CA7-AD57-45112B758126 wds:Q63199205-F3D17721-7D48-4F51-A980-26289B6424DC wds:Q63199205-FF32CF89-E28B-4268-9BE3-E7F953D80710
cites work	Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02 Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study Nonparametric Estimation from Incomplete Observations Cancer statistics, 1998. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer Adjuvant chemotherapy for high-risk endometrial cancer Uterine papillary serous carcinoma: a review Doxorubicin-cisplatin-vinblastine combination chemotherapy of advanced endometrial carcinoma: a Southwest Oncology Group Study Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC) for early-stage high-risk endometrial cancer: a preliminary analysis Cisplatin, doxorubicin hydrochloride, and cyclophosphamide followed by radiotherapy in high-risk endometrial carcinoma Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy Chemotherapy as adjuvant and salvage treatment in women with endometrial carcinoma Adjuvant chemotherapy including cisplatin in endometrial carcinoma Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide Serous papillary carcinoma of the endometrium: a histopathological study of 22 cases Pathologic stage III endometrial carcinoma. Prognostic factors and patterns of recurrence Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy. Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC) Adjuvant whole abdominopelvic irradiation for high risk endometrial carcinoma Role of whole abdominal radiation therapy in the management of endometrial cancer; prognostic importance of factors indicating peritoneal metastases A new aggressive treatment approach to high-grade endometrial cancer of possible benefit to patients with stage I uterine papillary cancer Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC) Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma Improved outcome in patients treated with postoperative radiation therapy for pathologic stage I/II endometrial cancer Surgery and postoperative radiation therapy in stage II endometrial carcinoma Tailoring radiation to the extent of disease for uterine-confined endometrial cancer External pelvic radiation therapy in stage IC endometrial carcinoma The importance of local-regional radiotherapy with conventional or high-dose chemotherapy in the management of breast cancer patients with > or = 10 positive axillary nodes
author name string	wds:Q63199205-01979FB0-24A4-477A-8FDC-80441243403D wds:Q63199205-0576CC4F-0D5A-4613-9937-551D585B6DCA wds:Q63199205-3B692FDA-86F8-46F6-80CE-42C20093CBE7 wds:Q63199205-4D802C2B-DA6D-45E7-B03F-06AFC0E217AF wds:Q63199205-7756F850-F493-4890-957A-FC56D6153A87 wds:Q63199205-F20FC17C-4B6D-44B4-8473-6B73918B1213
OpenCitations bibliographic resource ID	wds:Q63199205-7908A5B5-7869-405E-AFAF-CFFDFEF02837
OpenCitations bibliographic resource ID	https://w3id.org/oc/corpus/br/454
author name string	R McBride J Rotmensch A J Mundt P P Connell S E Waggoner S D Yamada
OpenCitations bibliographic resource ID	454
rdfs:label	Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy (en) Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy (nl)
skos:prefLabel	Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy (en) Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy (nl)
name	Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy (en) Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy (nl)
title	wds:Q63199205-2B7FECAC-7374-4C19-A67E-902B5F7B33DC
title	Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy (en)
page(s)	wds:Q63199205-BA4F12C9-A204-475C-BD03-180AF714E370

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software